ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)

China · Delayed Price · Currency is CNY

10.37

-0.39 (-3.62%)

Nov 13, 2026, 3:00 PM CST

Market Cap	5.10B -5.2%
Revenue (ttm)	3.75B +3.2%
Net Income	356.64M +42.6%
EPS	0.73 +20.2%
Shares Out	492.21M
PE Ratio	14.13
Forward PE	n/a
Dividend	0.36 (3.47%)
Ex-Dividend Date	Oct 27, 2026

Volume	16,573,550
Open	10.76
Previous Close	10.76
Day's Range	10.31 - 10.77
52-Week Range	9.20 - 15.25
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHA:600479

ZhuZhou QianJin Pharmaceutical Co.,Ltd engages in the production and sales of Chinese and Western medicines in China. The company offers traditional chinese medicine that cover areas, such as pelvic inflammatory disease, menstrual disorders, cervicitis, dysfunctional uterine bleeding, breast hyperplasia, postpartum blood and qi deficiency, and menopausal syndrome; chemical products that covers areas, including gynecology, cardiovascular system, endocrine system, liver and kidney diseases, oncology and immune system, antiviral, psychotropic, and... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1966

Employees 5,041

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600479

Full Company Profile

Financial Performance

In 2025, SHA:600479's revenue was 3.63 billion, a decrease of -0.03% compared to the previous year's 3.63 billion. Earnings were 286.29 million, an increase of 24.07%.

Financial Statements